NEVVI Medicare utilization intelligence
or

← back

Provider profile

STASZEWSKI, HARRY M.D.

Hematology-Oncology · NPI 1366495509 · MINEOLA, NY

1
Groups
94
Codes · 2024
169,445
Disclosed services

STASZEWSKI, HARRY is a Hematology-Oncology in MINEOLA, NY, a member of 1 medical group, who billed 94 distinct codes to Medicare Part B in 2024.

Groups: NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (SMITHTOWN, NY)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

169,445
disclosed services
94
codes billed to Medicare Part B
Prior year · CY2023 118,125 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0896 Injection, luspatercept-aamt, 0.25 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1756 Injection, iron sucrose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
80053 Blood test, comprehensive group of blood chemicals
88185 Flow cytometry technique for dna or cell analysis, each additional marker
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83615 Lactate dehydrogenase (enzyme) level
82784 Gammaglobulin (immune system protein) measurement
84100 Phosphate level
82728 Ferritin (blood protein) level
83540 Iron level
83735 Magnesium level
84550 Uric acid level, blood
83550 Iron binding capacity
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
83521 Measurement of immunoglobulin light chains
85044 Red blood count, manual test
82607 Cyanocobalamin (vitamin b-12) level
96372 Injection of drug or substance under skin or into muscle
82746 Folic acid level, serum
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
84165 Protein measurement, serum
96361 Infusion into a vein for hydration, each additional hour
86334 Immunologic analysis technique on serum (immunofixation)
82378 Carcinoembryonic antigen (cea) protein level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J9045 Injection, carboplatin, 50 mg
84443 Blood test, thyroid stimulating hormone (tsh)
J3475 Injection, magnesium sulfate, per 500 mg
96374 Injection of drug or substance into vein
85610 Blood test, clotting time
J2405 Injection, ondansetron hydrochloride, per 1 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
82306 Vitamin d-3 level
96417 Administration of additional new drug or substance into vein, 1 hour or less
J7050 Infusion, normal saline solution, 250 cc
84153 Psa (prostate specific antigen) measurement, total
96360 Infusion into a vein for hydration, 31-60 minutes
82232 Beta-2 microglobulin (protein) level
J7030 Infusion, normal saline solution , 1000 cc
82533 Cortisol (hormone) measurement, total
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
84439 Thyroxine (thyroid chemical), free
83010 Haptoglobin (serum protein) level
96415 Administration of chemotherapy into vein, each additional hour
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
81002 Urinalysis, manual test
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
88184 Flow cytometry technique for dna or cell analysis, first marker
83036 Hemoglobin a1c level
99195 Drawing of blood for a medical problem
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
84403 Testosterone (hormone) level, total
86147 Cardiolipin antibody (tissue antibody) measurement
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
80074 Acute hepatitis panel
84436 Thyroxine (thyroid chemical), total
96523 Irrigation of implanted venous access drug delivery device
G0008 Administration of influenza virus vaccine
82270 Stool analysis for blood to screen for colon tumors
83970 Parathormone (parathyroid hormone) level
90662 Influenza vaccine split virus, preservative free
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
80048 Blood test, basic group of blood chemicals (calcium, total)
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
80061 Blood test, lipids (cholesterol and triglycerides)
82040 Albumin (protein) level
82668 Erythropoietin (protein) level
85730 Coagulation assessment blood test, plasma or whole blood
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
82785 Ige (immune system protein) level
99495 Transitional care management services for problem of at least moderate complexity
G0452 Molecular pathology procedure; physician interpretation and report
J2060 Injection, lorazepam, 2 mg

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.